Fiera Capital (Europe) Ltd. - Q4 2013 holdings

$178 Million is the total value of Fiera Capital (Europe) Ltd.'s 65 reported holdings in Q4 2013. The portfolio turnover from Q3 2013 to Q4 2013 was 190.5% .

 Value Shares↓ Weighting
BIDU SellBAIDU INCspon adr rep a$22,205,000
-3.6%
125,310
-15.8%
12.46%
-8.3%
ITUB SellITAU UNIBANCO HOLDINGS SAsponsored adr rep pfd$20,168,000
-4.8%
1,484,552
-1.0%
11.31%
-9.6%
VALE NewVALE S Aadr$18,773,0001,231,395
+100.0%
10.53%
CTCM BuyCTC MEDIA INC$14,289,000
+52.9%
1,027,256
+15.5%
8.02%
+45.3%
BSAC BuyBANCO SANTANDER CHILE NEW$12,255,000
-1.0%
520,587
+10.3%
6.87%
-5.9%
PBRA BuyPETROLEO BRASILEIRO SA PETROsp adr non vtg$11,058,000
-5.9%
751,972
+6.7%
6.20%
-10.6%
EDU SellNEW ORIENTAL ED & TECH GRP Isponsored adr$10,347,000
+14.9%
328,327
-9.4%
5.80%
+9.2%
ABEV NewAMBEV SAsponsored adr$9,909,0001,347,323
+100.0%
5.56%
MBT NewMOBILE TELESYSTEMS OJSCsponsored adr$9,808,000453,355
+100.0%
5.50%
CCU BuyCOMPANIA CERVECERIAS UNIDASsponsored adr$8,438,000
+20.1%
350,273
+32.1%
4.73%
+14.2%
FMX SellFOMENTO ECONOMICO MEXICANO Ssponsored adr units$7,799,000
-3.5%
79,791
-4.3%
4.38%
-8.3%
CPA SellCOPA HOLDINGS SAcl a$5,688,000
-3.6%
35,571
-16.3%
3.19%
-8.4%
TV SellGRUPO TELEVISA SAsponsored adr rep ord$5,052,000
-4.4%
166,644
-11.8%
2.83%
-9.1%
BBD SellBANCO BRADESCO S Asp adr pfd new$4,917,000
-9.8%
392,289
-0.1%
2.76%
-14.3%
BAP BuyCREDICORP LTD$4,519,000
+6.9%
34,073
+3.3%
2.54%
+1.6%
BRFS BuyBRF SAsponsored adr$3,580,000
+528.1%
171,435
+637.9%
2.01%
+497.6%
GRAM BuyGRANA Y MONTERO S A Asponsored adr$3,276,000
+15.1%
154,265
+7.8%
1.84%
+9.5%
UGP NewULTRAPAR PARTICIPACOES S A$1,029,00043,587
+100.0%
0.58%
PBR BuyPETROLEO BRASILEIRO SA PETROsponsored adr$1,019,000
+6.3%
73,892
+18.7%
0.57%
+1.1%
PFE NewPFIZER INC$519,00016,929
+100.0%
0.29%
GGB BuyGERDAU S Asponsored adr rep pfd$457,000
+57.6%
58,256
+50.3%
0.26%
+49.7%
ARWR NewARROWHEAD RESH CORP$403,00037,165
+100.0%
0.23%
MRK NewMERCK & CO INC NEW$284,0005,686
+100.0%
0.16%
JNJ NewJOHNSON & JOHNSON$275,0003,008
+100.0%
0.15%
GILD NewGILEAD SCIENCES INC$225,0003,003
+100.0%
0.13%
ABBV NewABBVIE INC$199,0003,763
+100.0%
0.11%
AMGN NewAMGEN INC$157,0001,380
+100.0%
0.09%
SNY NewSANOFIsponsored adr$144,0002,700
+100.0%
0.08%
BMY NewBRISTOL MYERS SQUIBB CO$143,0002,700
+100.0%
0.08%
BIIB NewBIOGEN IDEC INC$122,000436
+100.0%
0.07%
AGN NewALLERGAN INC$109,000976
+100.0%
0.06%
ILMN NewILLUMINA INC$105,000952
+100.0%
0.06%
CELG NewCELGENE CORP$95,000563
+100.0%
0.05%
MDT NewMEDTRONIC INC$94,0001,641
+100.0%
0.05%
THRX NewTHERAVANCE INC$90,0002,535
+100.0%
0.05%
REGN NewREGENERON PHARMACEUTICALS$90,000325
+100.0%
0.05%
BAX NewBAXTER INTL INC$78,0001,121
+100.0%
0.04%
FRX NewFOREST LABS INC$67,0001,112
+100.0%
0.04%
ABT NewABBOTT LABS$64,0001,673
+100.0%
0.04%
MYL NewMYLAN INC$63,0001,451
+100.0%
0.04%
SPPI NewSPECTRUM PHARMACEUTICALS INC$38,0004,300
+100.0%
0.02%
Q NewQUINTILES TRANSNATIO HLDGS I$35,000746
+100.0%
0.02%
CBST NewCUBIST PHARMACEUTICALS INC$33,000477
+100.0%
0.02%
SLXP NewSALIX PHARMACEUTICALS INC$33,000370
+100.0%
0.02%
BSX NewBOSTON SCIENTIFIC CORP$33,0002,761
+100.0%
0.02%
CVD NewCOVANCE INC$33,000375
+100.0%
0.02%
MDVN NewMEDIVATION INC$32,000501
+100.0%
0.02%
WAT NewWATERS CORP$32,000315
+100.0%
0.02%
LIFE NewLIFE TECHNOLOGIES CORP$31,000414
+100.0%
0.02%
BMRN NewBIOMARIN PHARMACEUTICAL INC$31,000446
+100.0%
0.02%
SGEN NewSEATTLE GENETICS INC$29,000718
+100.0%
0.02%
LXFT ExitLUXOFT HLDG INC$0-81,200
-100.0%
-1.25%
VIP ExitVIMPELCOM LTDsponsored adr$0-190,000
-100.0%
-1.29%
CBD ExitCOMPANHIA BRASILEIRA DE DISTspn adr pfd cl a$0-56,240
-100.0%
-1.52%
ABV ExitCOMPANHIA DE BEBIDAS DAS AMEspon adr pfd$0-271,312
-100.0%
-6.16%
VAPE ExitVALE S Aadr$0-1,590,852
-100.0%
-14.63%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2014-02-11
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
JD.COM ADR16Q1 201718.4%
GENOMIC HEALTH INC16Q1 20179.1%
PFIZER INC16Q1 201713.5%
FOMENTO ECONOMIC ADR16Q1 20175.1%
BRISTOL MYERS SQUIBB16Q1 20174.8%
BECTON DICKINSON15Q1 201721.4%
AMGEN INC14Q1 20179.3%
BRASIL FOODS ADR14Q1 20178.1%
VALE S A14Q1 201713.5%
PHARMACYCLICS INC14Q1 20170.8%

View Fiera Capital (Europe) Ltd.'s complete holdings history.

Latest filings
TypeFiled
13F-NT2024-02-13
13F-NT2023-11-02
13F-NT2023-08-08
13F-NT2023-05-09
13F-NT2023-02-13
13F-NT2022-11-14
13F-NT2022-08-09
13F-NT2022-05-16
13F-NT2022-02-11
13F-NT2021-11-12

View Fiera Capital (Europe) Ltd.'s complete filings history.

Compare quarters

Export Fiera Capital (Europe) Ltd.'s holdings